Next Article in Journal
A High-Density EST-SSR-Based Genetic Map and QTL Analysis of Dwarf Trait in Cucurbita pepo L.
Previous Article in Journal
CPEB2 Is Necessary for Proper Porcine Meiotic Maturation and Embryonic Development
Previous Article in Special Issue
Methodological Approaches to Study Extracellular Vesicle miRNAs in Epstein–Barr Virus-Associated Cancers
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2018, 19(10), 3139;

MicroRNAs in Autoimmunity and Hematological Malignancies

Ageing Research Center and Translational medicine-CeSI-MeT, 66100 Chieti, Italy
Department of Medical, Oral and Biotechnological Sciences (DSMOB), “G. d’Annunzio” University Chieti-Pescara, 66100 Chieti, Italy
Harvard Medical School Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
Department of Medicine and Aging Science (DMSI), “G. d’Annunzio” University Chieti-Pescara, 66100 Chieti, Italy
Author to whom correspondence should be addressed.
Received: 26 September 2018 / Accepted: 2 October 2018 / Published: 12 October 2018
(This article belongs to the Special Issue The Role of MicroRNAs in Human Diseases)
Full-Text   |   PDF [342 KB, uploaded 12 October 2018]   |  


Autoimmunity and hematological malignancies are often concomitant in patients. A causal bidirectional relationship exists between them. Loss of immunological tolerance with inappropriate activation of the immune system, likely due to environmental and genetic factors, can represent a breeding ground for the appearance of cancer cells and, on the other hand, blood cancers are characterized by imbalanced immune cell subsets that could support the development of the autoimmune clone. Considerable effort has been made for understanding the proteins that have a relevant role in both processes; however, literature advances demonstrate that microRNAs (miRNAs) surface as the epigenetic regulators of those proteins and control networks linked to both autoimmunity and hematological malignancies. Here we review the most up-to-date findings regarding the miRNA-based molecular mechanisms that underpin autoimmunity and hematological malignancies. View Full-Text
Keywords: autoimmunity; leukemia; lymphoma; microRNAs autoimmunity; leukemia; lymphoma; microRNAs

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Marco, M.D.; Ramassone, A.; Pagotto, S.; Anastasiadou, E.; Veronese, A.; Visone, R. MicroRNAs in Autoimmunity and Hematological Malignancies. Int. J. Mol. Sci. 2018, 19, 3139.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top